Prostate Trials
| KEYNOTE-991 | A Phase 3, Randomized, Double-blind Trial of Pembrolizumab Plus Enzalutamide Plus ADT Versus Placebo Plus Enzalutamide Plus ADT in Participants with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC). |
| TRITON3 | A Multicentre, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician’s Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency. |
| Sexual Wellbeing | Sexual Wellbeing and Quality of Life after Prostate Cancer for Gay and Bisexual Men and their Partners. |